BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Orion Corporation 

P.O. Box 84
1111 Cedar Creek Road
Grafton  Wisconsin  53024  U.S.A.
Phone: 414-377-2210 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Bayer HealthCare Pharmaceuticals (BAYA.F) And Orion Corporation Initiate Phase 3 Trial Of ODM-201 In Men With High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 9/16/2014 8:05:55 AM
Aurigene Discovery Technologies Limited And Orion Corporation Announce Research, Collaboration And Option Agreement For Rights To Aurigene's Epigenetics Program For Pan BET And Selective BET Bromodomain Inhibitors 6/24/2014 7:37:26 AM
Merger Of Simbec & Orion Corporation To Create A New International Full-Service CRO 6/23/2014 8:24:10 AM
200,000 Orion Corporation A-Shares Converted Into B-Shares 6/13/2014 8:13:12 AM
Bayer AG (BAYZF) Pays $68 Million Upfront For Orion Corporation's Prostate Cancer Candidate ODM-201 6/2/2014 7:02:38 AM
Jubilant BioSys Ltd. And Orion Corporation Announce Unique Collaborative Discovery Program In Pain Management Area 5/13/2014 8:11:59 AM
Orion Corporation Interim Report January-March 2014 4/29/2014 9:38:57 AM
Publishing Of Orion Corporation's Interim Report For January-March 2014 On 29 April 2014 4/22/2014 9:01:15 AM
Orion Corporation Receives First Marketing Authorisations For Bufomix Easyhaler® Product 4/15/2014 9:32:44 AM
300,000 Orion Corporation A-Shares Converted Into B-Shares 4/15/2014 9:31:32 AM
12345